A genetics stem can look deceptively short: a young patient, several affected relatives, an unusual cancer, or a result from a genomic test. Yet FRACP genetics questions often test several decisions at once. You need to identify the inheritance pattern, recognize the likely diagnosis or test, interpret risk correctly, and choose the next clinical step without being distracted by interesting but irrelevant detail.
For the written examination, genetics is rarely about reciting every syndrome in a textbook. It is about applying a small number of principles accurately under time pressure. The trainees who improve fastest usually stop treating genetics as a collection of rare diseases and start seeing it as a structured reasoning task.
What FRACP genetics questions are really testing
Most genetics MCQs sit at the intersection of probability, phenotype recognition, and clinical judgment. A question may ask about a pedigree, but the best answer can depend on age of onset, penetrance, tumor surveillance, reproductive implications, or whether genetic counseling is needed before testing.
The first task is to decide what type of problem you are facing. Is this primarily an inheritance question? A syndrome-recognition question? A test-selection question? Or a question about what a result means for the patient and family? Naming that task early prevents the common error of jumping straight to a familiar diagnosis.
A useful internal sequence is: define the phenotype, identify the inheritance clues, consider the appropriate test or diagnosis, then ask what action follows. This sequence is not rigid. Some stems give you a pathogenic variant immediately, while others expect you to infer one. But it keeps your reasoning clinically grounded.
Read the pedigree before doing the math
Pedigrees are high-yield because they can rapidly narrow the field. Vertical transmission through successive generations suggests autosomal dominant inheritance, especially where both sexes are affected and male-to-male transmission occurs. Affected siblings with unaffected parents raises autosomal recessive inheritance, particularly with consanguinity or a shared ancestral background. X-linked patterns require closer attention to sex distribution and transmission through unaffected female carriers.
Do not overcall a pattern from a tiny family. A dominant condition may appear to skip a generation because of reduced penetrance, variable expression, early death, or incomplete family history. Likewise, a new pathogenic variant can produce an apparently isolated case. When the pedigree is ambiguous, let the phenotype and the wording of the stem carry more weight than a forced inheritance label.
Mitochondrial inheritance is another classic trap. An affected mother can transmit a variant to all children, but expression may vary substantially because of heteroplasmy. An affected father does not transmit mitochondrial DNA to his children. The exam may not always require you to name heteroplasmy, but recognizing why relatives have different severity can distinguish a good answer from an overconfident one.
Build a framework for FRACP genetics questions
Genetics becomes more manageable when you revise it in recurring clinical frames rather than as an isolated specialty. Connect genetic mechanisms to the presentations you see across adult medicine: premature cardiovascular disease, unexplained cardiomyopathy, young-onset malignancy, renal disease, neuromuscular syndromes, metabolic disorders, and endocrine neoplasia.
For each condition or condition group, know four things: the clinical clue that should trigger suspicion, the likely inheritance pattern, the role and limits of genetic testing, and the management implication. The management implication matters because it is frequently where MCQ options separate. A correct diagnosis does not automatically mean immediate testing is the best next step.
For example, a phenotype strongly suggestive of an inherited cancer syndrome may require referral for genetic counseling and targeted assessment. A broad panel ordered without considering the patient’s phenotype may generate uncertain findings that do not clarify management. In another stem, the correct answer may be cascade testing of relatives after a familial pathogenic variant has been identified, rather than repeating extensive testing in each family member.
Know what a genetic result can and cannot tell you
Questions on test interpretation reward precise language. A pathogenic or likely pathogenic variant may establish or strongly support a molecular diagnosis in the right clinical context. A negative result does not always exclude a genetic condition. The test may not detect all variant types, the causative gene may be unknown, or the patient may have been tested with an inappropriate method.
A variant of uncertain significance is not a diagnosis and should not usually drive irreversible management decisions or predictive testing in unaffected relatives. This is a frequent examination principle because it tests restraint. When an option treats a variant of uncertain significance as proof of disease, it is usually wrong.
Also distinguish diagnostic testing from predictive testing. Diagnostic testing is performed in someone with symptoms or a suggestive phenotype. Predictive testing evaluates risk in an unaffected relative when a familial pathogenic variant is known. The clinical, ethical, and counseling requirements can differ. If a stem emphasizes anxiety, family planning, or implications for relatives, think beyond the laboratory result.
Use probability carefully
Risk calculations are often simple but easily mishandled. In autosomal dominant disease, each child of a heterozygous affected parent has a 50% chance of inheriting the variant. That chance is independent for each pregnancy. In autosomal recessive disease, two carrier parents have a 25% chance of an affected child with each pregnancy.
The wrinkle is penetrance. Inheriting a variant is not always equivalent to developing the phenotype. Age-related penetrance is especially relevant in adult medicine. A relative may test positive but remain clinically unaffected at the time of testing, while still needing surveillance. Conversely, a negative predictive result for a known familial pathogenic variant can substantially change follow-up requirements.
If a question includes prior probability, screening results, or a family history that modifies risk, slow down. The best answer may depend on whether the patient is at population risk, has a first-degree relative, or already meets clinical diagnostic criteria. Do not apply a headline percentage without checking whose risk the question is actually asking about.
A practical way to answer the stem
Under exam conditions, use the answer options as diagnostic tools. Before selecting an option, identify the one fact in the stem that makes the case genetic rather than simply medical. It might be bilateral disease, a striking age of onset, a characteristic combination of organ involvement, or a pattern across relatives.
Then test each option against the question being asked. If it asks for the next best step, avoid answers that are true but premature. If it asks for the most likely mechanism, do not choose a management plan. If it asks what a result means, separate biological plausibility from what can be concluded clinically.
Watch for absolute wording. Phrases such as “rules out,” “always,” “all relatives,” or “no further follow-up” deserve scrutiny in genetics because exceptions are common. At the same time, do not reject an answer merely because it sounds decisive. When a pathogenic familial variant and the relevant clinical context are clear, targeted testing and surveillance recommendations can be appropriately direct.
Turn missed questions into revision gains
A missed genetics question should produce more than a corrected answer. Record the error by category: inheritance, syndrome recognition, test interpretation, probability, or management. This quickly shows whether your gap is knowledge-based or caused by rushing the stem.
When reviewing MCQs, write one short rule you could apply to a future case. For example: a variant of uncertain significance does not confirm a hereditary syndrome; negative testing does not necessarily exclude a clinically suspected disorder; or an unaffected person should not be assumed to be low risk before age-related penetrance is considered. These rules are easier to retrieve than long notes during a busy rotation.
Repeated, specialty-specific question practice is particularly useful here because genetics concepts recur in different clinical clothing. A cardiology question about inherited cardiomyopathy, an oncology question about familial cancer risk, and a nephrology question about inherited renal disease may test the same core principles. FRACPractice is designed to help trainees identify those cross-specialty patterns through targeted MCQs, explanations, and visible progress tracking.
Study broadly, but prioritize decisions
There is a trade-off in genetics revision. Memorizing more syndromes can improve recognition, but it is inefficient if you cannot decide what to do once you recognize one. Start with common, clinically consequential patterns and the testing principles that apply across specialties. Add rare syndromes when they are linked to a memorable phenotype or a frequently tested management decision.
Give particular attention to scenarios where genetics changes care for more than one person. Cascade testing, surveillance of at-risk relatives, reproductive counseling, and the limits of consent are not peripheral details. They reflect the family-based nature of genetic medicine and frequently explain why one otherwise plausible answer is better than another.
The aim is not to become a clinical geneticist before the written examination. It is to become reliable at recognizing when genetic reasoning changes diagnosis, risk, testing, and management. Each carefully reviewed question adds another pattern you can use when the next short, information-dense stem appears on exam day.